Skip to main content
SpringerLink
Log in
Book cover

Medikamentöse Behandlung des Postinfarktpatienten nach CAST pp 1–9Cite as

Pharmakologie der Antiarrhythmika

  • Conference paper

  • 20 Accesses

Zusammenfassung

Die medikamentöse Behandlung von Arrhythmien bei Patienten in der chronischen Phase des Myokardinfarktes ist im Jahre 1 nach CAST einer besonders kritischen Bewertung zu unterziehen. Die therapeutischen Intentionen sind auf die Prophylaxe und Therapie maligner ventrikulärer Arrhythmien mit dem Ziel der Prävention eines plötzlichen Herztodes ausgerichtet.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brogden RN, Todd PA (1987) Disopyramide: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias. Drugs 34: 151–187

    Article  PubMed  CAS  Google Scholar 

  2. Danilo P (1979) Mexiletine. Am Heart J 97: 399–403

    Article  PubMed  Google Scholar 

  3. Dreifus LS, Ogawa S (1977) Quality of the ideal antiarrhythmic drug. Am J Cardiol 39: 466–468

    Article  PubMed  CAS  Google Scholar 

  4. Harron DWG, Brogden RN (1987) Propafenone: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 34: 617–647

    Article  PubMed  CAS  Google Scholar 

  5. Holmes B, Heel RC (1985) Flecainide: A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29: 1–33

    Article  PubMed  CAS  Google Scholar 

  6. Holt DW, Tucker GT, Jackson PR, Storey GCA (1983) Amiodarone pharmacokinetics. Am Heart J 106: 840–847

    Article  PubMed  CAS  Google Scholar 

  7. Landmark K, Bredesen JE, Thaulow E, Simonsen S, Amlie JP (1981) Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure. Eur J clin Pharmacol 19: 187–192

    Article  PubMed  CAS  Google Scholar 

  8. Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano Ch, Lineberry MD, Wood AJJ, Roden DM, Woosley RL (1990) The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone. New Engl J Med 322: 1764–1768

    Article  PubMed  CAS  Google Scholar 

  9. Morganroth J, Horowitz LN (1984) Flecainide: Its pro-arrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol 53: 89B–94B

    Article  PubMed  Google Scholar 

  10. Pentikäinen PJ, Halinen MO, Helin MJ (1984) Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction. J cardiovasc Pharmacol 6: 1–6

    Article  PubMed  Google Scholar 

  11. Podrid PJ (1983) Aggravation of arrhythmias: A potential complication of therapy. Prim Cardiol 9: 75–87

    Google Scholar 

  12. Puech P (1990) Practical aspects of the use of amiodarone. Drugs 41 (Suppl): 13–19

    Google Scholar 

  13. Rostock G (1989) Klinisch-pharmakologische Untersuchungen der Antiarrhythmika Tiracizin und Disopyramid. Habilitationsschrift, Berlin

    Google Scholar 

  14. Rostock G, Rostock KJ, Vogel I, Faulhaber HD (1988) Klinische Pharmakokinetik von Bonnecor und seinen Metaboliten. In: Arzneimittelwerk Dresden GmbH (Hrsg) Symposium über Bonnecor, Dresden 26.–27. 10. 1988, S 66–75

    Google Scholar 

  15. Rostock KJ, Rathgen K, Rostock G, Volkmann, H, Pfeiffer D (1990) Klinische Wirksamkeit von Bonnecor bei oraler Langzeitgabe. Medicamentum 31: 53–57

    Google Scholar 

  16. Siddoway LA, Woosley RL (1986) Clinical pharmacokinetics of disopyramide. Clin Pharmacokin 11: 214–222

    Article  CAS  Google Scholar 

  17. Torres V, Flowers D, Somberg JC (1985): The arrhythmogenicity of antiarrhythmic agent. Am Heart J 109: 1090–1097

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Herz- und Kreislaufforschung, Wiltbergstraße 50, O-l115, Berlin-Buch, Germany

    Frau Dr. sc. med. G. Rostock

Authors
  1. Frau Dr. sc. med. G. Rostock
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Klinik, Technischen Universität München Klinikum rechts der Isar, Ismaninger Straße 22, 8000, München 80, Germany

    Georg Schmidt

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Rostock, G. (1991). Pharmakologie der Antiarrhythmika. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85414-9_1

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85415-6

  • Online ISBN: 978-3-642-85414-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation